218.11MMarket Cap-2128P/E (TTM)
1.490High1.350Low3.24MVolume1.380Open1.350Pre Close4.61MTurnover3.10%Turnover RatioLossP/E (Static)146.38MShares1.92052wk High4.22P/B155.56MFloat Cap0.36052wk Low--Dividend TTM104.41MShs Float24.570Historical High--Div YieldTTM10.37%Amplitude0.271Historical Low1.424Avg Price1Lot Size
Veru Inc Stock Forum
Pop early IMO..
Veru Enrolls First Patients In Phase 2b Clini - moomoo
-- The Phase 2b study planned to be conducted in 15 clinical sites in the United States --
-- Topline clinical data expected in the fourth quarter calendar year 2024 --
MIAMI, FL, April 30, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ:VERU), a late clinical stage biopharmaceutical company focused on developing innovative medic...
The bullish case only gets stronger once investors take into account VERU's positive earnings outlook for the current quarter. There have been 1 upwards revisions compared to no...
Tomorrows watch list for me
$SNDL Inc(SNDL.US)$
$Cumberland Pharmaceuticals(CPIX.US)$
$Sonoma Pharmaceuticals(SNOA.US)$
$Ispire Technology(ISPR.US)$
$Veru Inc(VERU.US)$
$Greenlane(GNLN.US)$
$OrganiGram(OGI.US)$
$Cronos Group(CRON.US)$
$GrowGeneration(GRWG.US)$
...
NEWS
Veru Enrolls First Patients in Phase 2b Clinical Trial of Enobosarm and Semaglutide Combination for High Quality Weight Loss
No comment yet